| Technology Overview AC-04
|
| Technology |
Novel Anti-mitotic Agent for Cancer Treatment |
| Mechanism |
Inhibits microtubule-polymerization which leads to growth inhibition and apoptosis |
| Indication |
Small molecule agents for cancer treatment |
| Efficacy |
AC-04 inhibits tumor growth, and improves the survival rate in animal models of breast, ovarian and colon cancers. |
| Development Stage |
Pre-clinical Stage
|
| Intellectual Property |
PCT Patent Pending(PCT/US07/025056) , TW Patent Pending(200831094) |
| Collaboration Opportunity |
Technology licensing, Co-development, or Research collaboration |
